Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer

被引：18

作者：

Shitara, K. ^{[1
]}

Fleitas, T. ^{[2
]}

Kawakami, H. ^{[3
]}

Curigliano, G. ^{[4
,5
]}

Narita, Y. ^{[6
]}

Wang, F. ^{[7
]}

Wardhani, S. O. ^{[8
]}

Basade, M. ^{[9
,10
]}

Rha, S. Y. ^{[11
]}

Zamaniah, W. I. Wan ^{[12
]}

Sacdalan, D. L. ^{[13
]}

Ng, M. ^{[14
]}

Yeh, K. H. ^{[15
,16
]}

Sunpaweravong, P. ^{[17
]}

Sirachainan, E. ^{[18
]}

Chen, M. -h. ^{[19
]}

Yong, W. P. ^{[20
]}

Peneyra, J. L. ^{[21
]}

Ibtisam, M. N. ^{[22
]}

Lee, K. -w. ^{[23
]}

Krishna, V. ^{[24
]}

Pribadi, R. R. ^{[25
]}

Li, J. ^{[26
]}

Lui, A. ^{[27
]}

Yoshino, T. ^{[1
]}

Baba, E. ^{[28
]}

Nakayama, I. ^{[29
]}

Pentheroudakis, G. ^{[30
]}

Shoji, H. ^{[31
]}

Cervantes, A. ^{[32
,33
]}

Ishioka, C. ^{[34
]}

Smyth, E. ^{[35
]}

机构：

[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan

[2] Hosp Clin Univ Valencia, INCL Biomed Res Inst, Dept Med Oncol, Valencia, Spain

[3] Kindai Univ, Dept Med Oncol, Fac Med, Osakasayama, Japan

[4] Ist Europeo Oncol, IRCCS, Milan, Italy

[5] Univ Milan, Dept Oncol & Haemato Oncol, Milan, Italy

[6] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Japan

[7] Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou, Peoples R China

[8] Brawijaya Univ, Div Med Hematol Oncol, Dept Internal Med, Dr Saiful Anwar Gen Hosp Malang, East Java, Indonesia

[9] Jaslok Hosp, Dept Med Oncol, Mumbai, India

[10] Breach Candy Hosp, Mumbai, India

[11] Yonsei Univ, Coll Med, Dept Internal Med, Yonsei Canc Ctr,Yonsei Univ Hlth Syst, Seoul 120752, South Korea

[12] Univ Malaya, Fac Med, Clin Oncol Unit, Kuala Lumpur, Malaysia

[13] Univ Philippines, Dept Med, Div Med Oncol, The Philippines, Manila, Philippines

[14] Natl Canc Ctr Singapore, Dept GI Oncol, Singapore, Singapore

[15] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[16] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan

[17] Prince Songkla Univ, Fac Med, Dept Med, Div Med Oncol, Hat Yai, Thailand

[18] Mahidol Univ, Fac Med Ramathibodi Hosp, Dept Med, Div Med Oncol, Bangkok, Thailand

[19] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan

[20] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore

[21] San Juan De Dios Hosp, St Peregrine Oncol Unit, Pasay City, Philippines

[22] Gen Hosp Kuala Lumpur, Inst Radiotherapy & Oncol, Kuala Lumpur, Malaysia

[23] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med,Bundang Hosp, Seoul, South Korea

[24] AIG Hosp, Dept Med Oncol, Hyderabad, India

[25] Univ Indonesia, Dr Cipto Mangunkusumo Natl Gen Hosp, Fac Med, Dept Internal Med, Jakarta, Indonesia

[26] Univ Tongji, Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

[27] Southern Philippines Med Ctr ESM, Dept Internal Med, Sect Med Oncol, Davao, Philippines

[28] Kyushu Univ, Grad Sch Med Sci, Dept Oncol & Social Med, Fukuoka, Japan

[29] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Gastroenterol Chemotherapy, Tokyo, Japan

[30] ESMO, Lugano, Switzerland

[31] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan

[32] Univ Valencia, INCLIVA Biomed Res Inst, Dept Med Oncol, Valencia, Spain

[33] Inst Salud Carlos III, CIBERONC, Madrid, Spain

[34] Tohoku Univ Hosp, Dept Med Oncol, Sendai, Japan

[35] Oxford Univ Hosp NHS Fdn Trust, Dept Oncol, Oxford, England

来源：

ESMO OPEN | 2024年 / 9卷 / 02期

关键词：

ESMO; guidelines; Pan-Asian; gastric cancer; treatment; GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA; PEMBROLIZUMAB PLUS CHEMOTHERAPY; WESTERN PATIENTS PTS; DERUXTECAN T-DXD; PHASE-III TRIAL; DOUBLE-BLIND; STAGING LAPAROSCOPY; OPEN-LABEL; HELICOBACTER-PYLORI; PERIOPERATIVE CHEMOTHERAPY;

D O I：

10.1016/j.esmoop.2023.102226

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and followup of patients with gastric cancer (GC), published in late 2022 and the updated ESMO Gastric Cancer Living Guideline published in July 2023, were adapted in August 2023, according to previously established standard methodology, to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for the management of Asian patients with GC. The adapted guidelines presented in this manuscript represent the consensus opinions reached by a panel of Asian experts in the treatment of patients with GC representing the oncological societies of China (CSCO), Indonesia (ISHMO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO), coordinated by ESMO and the Japanese Society of Medical Oncology (JSMO). The voting was based on scienti fi c evidence and was independent of the current treatment practices, drug access restrictions and reimbursement decisions in the different Asian regions represented by the 10 oncological societies. The latter are discussed separately in the manuscript. The aim is to provide guidance for the optimisation and harmonisation of the management of patients with GC across the different regions of Asia, drawing on the evidence provided by both Western and Asian trials, whilst respecting the differences in screening practices, molecular pro fi ling and age and stage at presentation. Attention is drawn to the disparity in the drug approvals and reimbursement strategies, between the different regions of Asia.

引用

页数：20

共 50 条

[11] Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer
Lee, S. -h.
Menis, J.
Kim, T. M.
Kim, H. R.
Zhou, C.
Kurniawati, S. A.
Prabhash, K.
Hayashi, H.
Lee, D. d. -w.
Imasa, M. S.
Teh, Y. L.
Yang, J. c. -h.
Reungwetwattana, T.
Sriuranpong, V.
Wu, C. -e.
Ang, Y.
Sabando, M.
Thiagarajan, M.
Mizugaki, H.
Noronha, V.
Yulianti, M.
Zhang, L.
Smyth, E.
Yoshino, T.
Park, J. O.
Pentheroudakis, G.
Park, S.
Peters, S.
Ahn, J. B.
Popat, S.
ESMO OPEN, 2024, 9 (12)
[12] Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Smyth, E. C.
Verheij, M.
Allum, W.
Cunningham, D.
Cervantes, A.
Arnold, D.
ANNALS OF ONCOLOGY, 2016, 27 : v38 - v49
[13] Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Okines, A.
Verheij, M.
Allum, W.
Cunningham, D.
Cervantes, A.
ANNALS OF ONCOLOGY, 2010, 21 : v50 - v54
[14] Pan-Asian adapted ESMO guidelines for the management of patients with metastatic oesophageal and gastric cancer
Muro, Kei
ANNALS OF ONCOLOGY, 2018, 29 : 16 - 16
[15] Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck
Keam, B.
Machiels, J-P
Kim, H. R.
Licitra, L.
Golusinski, W.
Gregoire, V
Lee, Y. G.
Belka, C.
Guo, Y.
Rajappa, S. J.
Tahara, M.
Azrif, M.
Ang, M. K.
Yang, M-H
Wang, C-H
Ng, Q. S.
Zamaniah, W. I. Wan
Kiyota, N.
Babu, S.
Yang, K.
Curigliano, G.
Peters, S.
Kim, T. W.
Yoshino, T.
Pentheroudakis, G.
ESMO OPEN, 2021, 6 (06)
[16] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pacini, F.
Castagna, M. G.
Brilli, L.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2012, 23 : 110 - 119
[17] Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Haie-Meder, C.
Morice, P.
Castiglione, M.
ANNALS OF ONCOLOGY, 2010, 21 : v37 - v40
[18] Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bellmunt, J.
Orsola, A.
Wiegel, T.
Guix, M.
De Santis, M.
Kataja, V.
ANNALS OF ONCOLOGY, 2011, 22 : vi45 - vi49
[19] Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Berruti, A.
Baudin, E.
Gelderblom, H.
Haak, H. R.
Porpiglia, F.
Fassnacht, M.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2012, 23 : 131 - 138
[20] Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Horwich, A.
Parker, C.
de Reijke, T.
Kataja, V.
ANNALS OF ONCOLOGY, 2013, 24 : 106 - 114

← 1 2 3 4 5 →